Perimeter Medical Imaging AI (4PC) Ratios

1 Followers

Perimeter Medical Imaging AI Ratios

DE:4PC's free cash flow for Q4 2025 was C$0.61. For the 2025 fiscal year, DE:4PC's free cash flow was decreased by C$ and operating cash flow was C$-2.74. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Dec 24	Dec 23	Mar 23
Liquidity Ratios
Current Ratio	―	1.56	2.79	3.36	3.92
Quick Ratio	―	1.53	2.73	3.34	3.91
Cash Ratio	―	1.17	1.73	2.02	3.54
Solvency Ratio	―	-4.74	-3.27	-2.58	-0.30
Operating Cash Flow Ratio	―	-4.47	-4.12	-2.13	-1.48
Short-Term Operating Cash Flow Coverage	―	-155.65	0.00	0.00	-107.52
Net Current Asset Value	C$ ―	C$ 697.32K	C$ 6.10M	C$ 16.09M	C$ 23.01M
Leverage Ratios
Debt-to-Assets Ratio	―	0.02	<0.01	<0.01	<0.01
Debt-to-Equity Ratio	―	0.03	0.01	0.01	0.01
Debt-to-Capital Ratio	―	0.03	0.01	0.01	0.01
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00	<0.01
Financial Leverage Ratio	―	1.63	1.37	1.80	1.33
Debt Service Coverage Ratio	―	-148.22	-484.44	0.00	-25.07
Interest Coverage Ratio	―	-582.58	-717.02	0.00	-153.64
Debt to Market Cap	―	<0.01	0.00	0.00	<0.01
Interest Debt Per Share	―	<0.01	<0.01	<0.01	<0.01
Net Debt to EBITDA	―	0.19	0.48	0.76	2.40
Profitability Margins
Gross Profit Margin	―	44.09%	63.24%	51.15%	75.79%
EBIT Margin	―	-561.57%	-1579.76%	-4646.27%	-9611.82%
EBITDA Margin	―	-525.40%	-1493.53%	-4493.94%	-8826.52%
Operating Profit Margin	―	-561.57%	-2210.57%	-5137.06%	-12142.65%
Pretax Profit Margin	―	-560.66%	-1582.84%	-4694.58%	-7461.33%
Net Profit Margin	―	-560.66%	-1582.84%	-4694.58%	-2700.97%
Continuous Operations Profit Margin	―	-560.66%	-1582.84%	-4694.58%	-7461.33%
Net Income Per EBT	―	100.00%	100.00%	100.00%	36.20%
EBT Per EBIT	―	99.84%	71.60%	91.39%	61.45%
Return on Assets (ROA)	―	-195.71%	-93.49%	-69.94%	-10.37%
Return on Equity (ROE)	―	-319.00%	-128.11%	-125.75%	-13.74%
Return on Capital Employed (ROCE)	―	-285.52%	-173.99%	-102.73%	-60.71%
Return on Invested Capital (ROIC)	―	-281.82%	-173.24%	-102.48%	-21.85%
Return on Tangible Assets	―	-195.71%	-93.49%	-69.94%	-10.37%
Earnings Yield	―	-45.55%	-49.30%	-24.01%	-3.61%
Efficiency Ratios
Receivables Turnover	―	8.91	0.36	0.17	0.07
Payables Turnover	―	0.78	0.00	0.09	0.01
Inventory Turnover	―	19.94	1.62	1.53	0.75
Fixed Asset Turnover	―	0.68	0.19	0.10	0.04
Asset Turnover	―	0.35	0.06	0.01	<0.01
Working Capital Turnover Ratio	―	0.62	0.07	0.02	<0.01
Cash Conversion Cycle	―	-407.11	1.24K	-1.75K	-21.06K
Days of Sales Outstanding	―	40.97	1.02K	2.13K	5.43K
Days of Inventory Outstanding	―	18.30	224.78	238.87	486.98
Days of Payables Outstanding	―	466.39	0.00	4.11K	26.98K
Operating Cycle	―	59.28	1.24K	2.36K	5.92K
Cash Flow Ratios
Operating Cash Flow Per Share	―	-0.11	-0.21	-0.23	-0.20
Free Cash Flow Per Share	―	-0.12	-0.24	-0.23	-0.23
CapEx Per Share	―	<0.01	0.03	<0.01	0.03
Free Cash Flow to Operating Cash Flow	―	1.01	1.15	1.03	1.17
Dividend Paid and CapEx Coverage Ratio	―	-72.19	-6.76	-30.97	-5.96
Capital Expenditure Coverage Ratio	―	-72.19	-6.76	-30.97	-5.96
Operating Cash Flow Coverage Ratio	―	-79.06	-107.09	-76.19	-36.44
Operating Cash Flow to Sales Ratio	―	-4.02	-17.40	-36.42	-89.39
Free Cash Flow Yield	―	-33.09%	-62.21%	-19.23%	-13.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-1.60	-1.41	-4.16	-27.72
Price-to-Sales (P/S) Ratio	―	8.96	22.31	195.52	748.76
Price-to-Book (P/B) Ratio	―	5.10	1.81	5.24	3.81
Price-to-Free Cash Flow (P/FCF) Ratio	―	-2.20	-1.12	-5.20	-7.17
Price-to-Operating Cash Flow Ratio	―	-2.23	-1.28	-5.37	-8.38
Price-to-Earnings Growth (PEG) Ratio	―	0.10	0.04	-0.01	0.33
Price-to-Fair Value	―	5.10	1.81	5.24	3.81
Enterprise Value Multiple	―	-1.52	-1.02	-3.59	-6.08
Enterprise Value	―	26.50M	21.12M	65.11M	71.30M
EV to EBITDA	―	-2.15	-1.67	-3.59	-6.08
EV to Sales	―	11.31	24.96	161.35	537.01
EV to Free Cash Flow	―	-2.78	-1.25	-4.29	-5.14
EV to Operating Cash Flow	―	-2.81	-1.43	-4.43	-6.01
Tangible Book Value Per Share	―	0.05	0.15	0.31	0.43
Shareholders’ Equity Per Share	―	0.05	0.15	0.23	0.43
Tax and Other Ratios
Effective Tax Rate	―	0.00	0.00	>-0.01	0.64
Revenue Per Share	―	0.03	0.01	<0.01	<0.01
Net Income Per Share	―	-0.16	-0.19	-0.29	-0.06
Tax Burden	―	1.00	1.00	1.00	0.36
Interest Burden	―	1.00	1.00	1.01	0.78
Research & Development to Revenue	―	2.14	7.85	16.92	41.25
SG&A to Revenue	―	3.92	14.45	20.10	41.01
Stock-Based Compensation to Revenue	―	0.00	2.25	3.63	11.48
Income Quality	―	0.72	1.10	1.05	1.20

Currency in CAD